Matrix Metalloproteinase-9 (MMP-9)
Matrix metalloproteinase-9 (MMP-9), also known as gelatinase B or 92 kDa type IV collagenase, is a zinc-dependent endopeptidase belonging to the matrix metalloproteinase (MMP) family of extracellular matrix (ECM)-degrading enzymes.
Matrix metalloproteinase-9 (MMP-9), also known as gelatinase B or 92 kDa type IV collagenase, is a zinc-dependent endopeptidase belonging to the matrix metalloproteinase (MMP) family of extracellular matrix (ECM)-degrading enzymes. Encoded by the MMP9 gene, the protein is secreted as a zymogen and activated proteolytically in the pericellular space, where it cleaves a broad range of ECM substrates including type IV and V collagens, gelatin, laminin, and fibronectin fragments. MMP-9 is expressed in a wide variety of cell types—including neutrophils, macrophages, astrocytes, osteoclasts, and tumor cells—and its activity is tightly regulated at the transcriptional level by nuclear factor kappa B (NF-κB), Interleukin-6 (IL-6), and other inflammatory mediators, as well as post-translationally by endogenous inhibitors such as TIMP-1 and TIMP-2. As a central effector of ECM remodeling, MMP-9 participates in physiological processes including wound healing, angiogenesis, and bone resorption, but its dysregulation underlies the pathophysiology of cancer invasion and metastasis, neuroinflammation, ischemic injury, vascular disease, and chronic inflammatory conditions.
Beyond its canonical ECM-degrading role, MMP-9 has emerged as a critical mediator of synaptic plasticity, memory consolidation, and reconsolidation in the central nervous system. It cleaves perisynaptic matrix components to facilitate structural remodeling at the synapse and modulates integrin signaling and NMDA receptor function, thereby influencing long-term potentiation. This dual identity—as both a peripheral tissue remodeler and a neuroplasticity regulator—has positioned MMP-9 as a high-priority pharmacological target across oncology, neuroscience, cardiology, and musculoskeletal medicine.
Where the papers sit
17 papers from the last 6 months study Matrix Metalloproteinase-9 (MMP-9) directly · updated from PubMed 16 Nov 2026
Study type 1 clinical trial · 4 human data · 7 preclinical · 5 unclassified
Themes one subject
Those 17 are all about one subject.
-
MMP-9 in Disease
MMP-9 is examined as a context-dependent mediator of tissue injury, remodeling and disease progression. Recurring settings include cancer invasion, diabetic neuropathy and wounds, renal fibrosis, osteoarthritis, neurodegeneration, pregnancy loss and infection. Studies pair mechanistic pathways such as p38 MAPK, extracellular-matrix remodeling and immune dysregulation with therapeutic inhibition, biomarker detection or drug repurposing. The breadth of endpoints supports disease-specific investigation rather than a single shared treatment direction.
Papers
The 17 papers from the last 6 months that study Matrix Metalloproteinase-9 (MMP-9) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
MMP-9 in Disease (17)
- In Silico Prioritization of Potential Protein Interactions for Glutathione-Responsive Abasic Site-Trapping Prodrugs in Non-Small Cell Lung Cancer. Journal of visualized experiments : JoVE · 30 Sept 2026 PMID 42813677
- Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers. Neurobiology of disease · 13 Sept 2026 PMID 42732855
- Monoclonal antibodies inhibiting MMP-9 activity alleviate peripheral neuropathy in diabetic mice. Science translational medicine · 9 Sept 2026 PMID 42715343
- Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 18 Aug 2026 PMID 42610529
- Interferon regulatory factor 5 in myeloid cells promotes obstructive nephropathy-induced renal fibrosis in vivo. JCI insight · 6 Aug 2026 PMID 42560765
- Ultrafast and ultrasensitive electrochemical aptasensor for multiplexed monitoring of hemorrhagic transformation biomarker in acute ischemic stroke. Biosensors & bioelectronics · 22 Jul 2026 PMID 42485702
- Network toxicology-driven repurposing of metformin for hepatocellular carcinoma: insights from molecular docking and dynamics simulations. Journal of molecular modeling · 18 Jul 2026 PMID 42470472
- Multi-omics analyses link dysregulated immune hemostasis to decreased endometrial MMP protein in recurrent pregnancy loss. Biology of reproduction · 14 Jul 2026 PMID 42446964
- Revealing the mechanism of heptamethoxyflavone against diabetic kidney disease: an integrated study combining network pharmacology, molecular docking and experimental validation. Biochemical and biophysical research communications · 13 Jul 2026 PMID 42442088
- Click-Chemistry-Based Antibacterial Hybrid Hydrogel with Sustained Puerarin Release for Diabetic Wound Healing. ACS applied bio materials · 4 Jul 2026 PMID 42400177
- MMP9 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced osteoarthritis cartilage damage via regulating the p38 MAPK pathway: A mechanistic study based on network toxicology and multi-omics. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2 Jul 2026 PMID 42392495
- Coordinated Regulation of TLR2 Signaling by Neu1 Sialidase and the Siglec-5/Siglec-14 Receptor Pair During Mycoplasma pneumoniae Infection. ACS infectious diseases · 25 Jun 2026 PMID 42350323
- Methodological study on simultaneous detection of 6 tumor invasion and metastasis markers including MMP-9 by microfluidic chip-based magnetic particle immunofluorescence assay. PloS one · 23 Jun 2026 PMID 42335133
- Bisphenol A exacerbates diabetic foot ulcers through disruption of immune microenvironment and repair processes: a multi-omics analysis of environmental exposure mechanisms. Drug and chemical toxicology · 15 Jun 2026 PMID 42298305
- Curcumin alleviates depression-aggravated psoriasis by targeting MMP9-regulated apoptotic pathways. iScience · 3 Jun 2026 PMID 42231964
- Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
- Multifunctional hybrid lipid-polymeric nanoparticle enabling resveratrol and siRNA co-delivery for enhanced cutaneous wound repair. Colloids and surfaces. B, Biointerfaces · 24 May 2026 PMID 42177899
By study type
Clinical trials (1)
- Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers. Neurobiology of disease · 13 Sept 2026 PMID 42732855
Human data, design not indexed (4)
- In Silico Prioritization of Potential Protein Interactions for Glutathione-Responsive Abasic Site-Trapping Prodrugs in Non-Small Cell Lung Cancer. Journal of visualized experiments : JoVE · 30 Sept 2026 PMID 42813677
- Ultrafast and ultrasensitive electrochemical aptasensor for multiplexed monitoring of hemorrhagic transformation biomarker in acute ischemic stroke. Biosensors & bioelectronics · 22 Jul 2026 PMID 42485702
- Network toxicology-driven repurposing of metformin for hepatocellular carcinoma: insights from molecular docking and dynamics simulations. Journal of molecular modeling · 18 Jul 2026 PMID 42470472
- Methodological study on simultaneous detection of 6 tumor invasion and metastasis markers including MMP-9 by microfluidic chip-based magnetic particle immunofluorescence assay. PloS one · 23 Jun 2026 PMID 42335133
Preclinical: animal, cell and lab studies (7)
- Monoclonal antibodies inhibiting MMP-9 activity alleviate peripheral neuropathy in diabetic mice. Science translational medicine · 9 Sept 2026 PMID 42715343
- Interferon regulatory factor 5 in myeloid cells promotes obstructive nephropathy-induced renal fibrosis in vivo. JCI insight · 6 Aug 2026 PMID 42560765
- Revealing the mechanism of heptamethoxyflavone against diabetic kidney disease: an integrated study combining network pharmacology, molecular docking and experimental validation. Biochemical and biophysical research communications · 13 Jul 2026 PMID 42442088
- Click-Chemistry-Based Antibacterial Hybrid Hydrogel with Sustained Puerarin Release for Diabetic Wound Healing. ACS applied bio materials · 4 Jul 2026 PMID 42400177
- Coordinated Regulation of TLR2 Signaling by Neu1 Sialidase and the Siglec-5/Siglec-14 Receptor Pair During Mycoplasma pneumoniae Infection. ACS infectious diseases · 25 Jun 2026 PMID 42350323
- Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
- Multifunctional hybrid lipid-polymeric nanoparticle enabling resveratrol and siRNA co-delivery for enhanced cutaneous wound repair. Colloids and surfaces. B, Biointerfaces · 24 May 2026 PMID 42177899
Unclassified: not yet indexed with MeSH (5)
- Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 18 Aug 2026 PMID 42610529
- Multi-omics analyses link dysregulated immune hemostasis to decreased endometrial MMP protein in recurrent pregnancy loss. Biology of reproduction · 14 Jul 2026 PMID 42446964
- MMP9 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced osteoarthritis cartilage damage via regulating the p38 MAPK pathway: A mechanistic study based on network toxicology and multi-omics. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2 Jul 2026 PMID 42392495
- Bisphenol A exacerbates diabetic foot ulcers through disruption of immune microenvironment and repair processes: a multi-omics analysis of environmental exposure mechanisms. Drug and chemical toxicology · 15 Jun 2026 PMID 42298305
- Curcumin alleviates depression-aggravated psoriasis by targeting MMP9-regulated apoptotic pathways. iScience · 3 Jun 2026 PMID 42231964
Written from 17 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-09-11 by GPT. Drafted by language models from published abstracts; not medical advice.